Buy Calquence 100mg Acalabrutinib

Calquence 100mg capsules contain acalabrutinib, a targeted therapy for certain blood cancers. This oral medication is prescribed by healthcare professionals to manage chronic lymphocytic leukemia and mantle cell lymphoma. Always follow your doctor's guidance when using this treatment.

Strength

100mg

Manufacturer / TM Owner

Astra Zeneca Operations AB Sweden

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Calquence 100mg capsules are prescribed for adults with chronic lymphocytic leukemia (CLL) or mantle cell lymphoma (MCL). This medication belongs to a class of drugs called BTK inhibitors, which work by blocking signals that help cancer cells grow. It is used when other treatments are not suitable or have not worked. Patients should discuss their specific condition with their healthcare provider.

Side Effects

Calquence 100mg capsules are taken by mouth and work systemically to target cancer cells. Common effects include mild nausea, headache, or fatigue, which may vary by individual. Some patients report temporary digestive discomfort or muscle and joint pain. These effects are typically monitored by a healthcare professional during treatment.

Precautions & Warnings

Keep Calquence 100mg capsules in their original packaging until use to protect from moisture. Store at room temperature away from direct sunlight and out of reach of children. Do not open, crush, or chew the capsules. If a dose is missed, contact your doctor for guidance rather than taking extra medication.

Avoid Interactions

Calquence may interact with other medications, including blood thinners, antifungals, and certain antibiotics. Grapefruit products and St. John’s wort can affect how this drug works. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Regular monitoring may be recommended during treatment.

References

Frequently Asked Questions

Calquence 100mg is prescribed to treat adults with chronic lymphocytic leukemia or mantle cell lymphoma.

Take Calquence exactly as directed by your doctor, usually once or twice daily with or without food.

Common effects may include headache, nausea, fatigue, or muscle and joint pain.

Avoid grapefruit products as they may interact with acalabrutinib.

No, Calquence is a targeted therapy known as a BTK inhibitor, not a traditional chemotherapy.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.